Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Med Mal Infect ; 49(8): 607-615, 2019 Nov.
Article in English | MEDLINE | ID: mdl-30871816

ABSTRACT

OBJECTIVES: Several non-invasive markers have recently been proposed to predict liver fibrosis without percutaneous liver biopsy (PLB). We aimed to evaluate the performance of non-invasive scores and to highlight the value of a new combined score in the prediction of liver fibrosis in chronic hepatitis B (CHB) patients. PATIENTS AND METHODS: We performed a retrospective study of patients presenting with CHB who underwent PLB between 2008 and 2016. We calculated ASAT/Platelet Ratio Index (APRI), Fibrosis-4 Score (FIB4), GGT-to-platelet ratio (GPR), and ASAT/ALAT Ratio (AAR). Then, we combined APRI and FIB-4 scores into a new combined score. We assessed their performance in predicting liver fibrosis according to the Metavir score. RESULTS: A total of 179 patients presenting with CHB were included. Multivariate analysis showed that the APRI score was the only independent factor of significant fibrosis (OR=3.78; P=0.02), whereas the FIB-4 score was the only independent factor for severe fibrosis (OR=2.85; P<0.001) and cirrhosis (OR=2.5; P=0.001). At a threshold of severe fibrosis, APRI had the best specificity (75%) and FIB-4 had the greatest sensitivity (74%). Using the combined score, we improved the diagnostic performance of APRI and FIB-4 scores at the three thresholds of liver fibrosis. With this combined score, maximum 25.1% of patients presenting with CHB would undergo PLB. CONCLUSION: APRI, FIB-4, and GPR scores were well performing to predict liver fibrosis during CHB. The new combined score using APRI and FIB-4 was more accurate at the three-fibrosis thresholds.


Subject(s)
Hepatitis B, Chronic/complications , Hepatitis B, Chronic/pathology , Liver Cirrhosis/etiology , Liver Cirrhosis/pathology , Models, Statistical , Adult , Biopsy , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Retrospective Studies
3.
Ann Med Interne (Paris) ; 152(2): 134-6, 2001 Mar.
Article in French | MEDLINE | ID: mdl-11357050

ABSTRACT

We report a case of Candida glabrata perinephric abscess in a patient with diabetes mellitus who recently underwent ureteropelvic surgery for lithiasic urinary tract obstruction. Surgical drainage and amphotericin B treatment led to resolution of the infection. C. glabrata urinary infection has become more prevalent over the last decade in immunocompromised patients. Drainage is indicated for development of a fungal abscess in the perinephric area. Most authors recommend administration of an antifungal adjuvant treatment.


Subject(s)
Abscess/diagnosis , Abscess/etiology , Candida , Candidiasis/diagnosis , Candidiasis/etiology , Diabetes Mellitus, Type 1/complications , Kidney Diseases/diagnosis , Kidney Diseases/etiology , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Urinary Calculi/surgery , Abscess/therapy , Aged , Amphotericin B/therapeutic use , Anti-Bacterial Agents/adverse effects , Antifungal Agents/therapeutic use , Candida/classification , Candidiasis/therapy , Combined Modality Therapy , Drainage , Escherichia coli Infections/drug therapy , Escherichia coli Infections/etiology , Female , Humans , Hypertension/complications , Immunocompromised Host , Kidney Diseases/therapy , Postoperative Complications/therapy , Risk Factors , Serotyping , Urinary Tract Infections/drug therapy , Urinary Tract Infections/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...